携带TARDBP致病性变异肌萎缩侧索硬化患者的认知与行为特征
该研究纳入2009-2021年都灵ALS专家中心接受广泛基因检测和神经心理成套测验的33例TARDBP致病性变异ALS患者、928例不携带该变异的ALS患者及129例匹配对照,比较认知行为特征。TARDBP-ALS与WT-ALS的认知分类无显著差异(p=0.623),但TARDBP-ALS在 executive functions、视觉记忆、视空间构造能力、词语流畅性和FrSBe冷漠行为成分上较对照表现更差。
要点
- TARDBP-ALS与WT-ALS的认知分类分布无显著差异(p=0.623)。
- TARDBP-ALS在 executive functions、视觉记忆、视空间构造能力、词语流畅性和冷漠行为成分上较对照更差。
- TARDBP-ALS与WT-ALS在所有测验得分上相似,包括ECAS所有子域。
核心结论
- TARDBP-ALS患者在多数检查域较对照显著更差,但与WT-ALS相比未显示特定认知损害模式。
研究设计与样本
- 研究纳入2009-2021年都灵ALS专家中心所有接受广泛基因检测和神经心理成套测验的ALS患者。
主要发现
- TARDBP-ALS与WT-ALS的认知分类分别为ALS-CN 54% vs 58.8%、ALSci 21.2% vs 18.3%、ALSci 9.1% vs 9.5%、ALScbi 6.1% vs 6.0%、ALS-FTD 9.1% vs 6.7%,无显著差异(p=0.623)。
- 与对照相比,TARDBP-ALS在 executive functions、视觉记忆、视空间构造能力、词语流畅性和FrSBe冷漠行为成分上表现更差。
- TARDBP-ALS与WT-ALS在所有测验得分上相似,包括ECAS所有子域。
临床怎么用
- 作者认为,考虑到认知损害对患者决策和照护者负担的影响,以及在设计针对TARDBP致病性变异患者的临床试验时,这些发现具有临床相关性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: TARDBP patients are considered particularly prone to cognitive involvement, but no systematic studies of cognitive impairment in TARDBP patients are available. The aim of this article was to depict in depth the cognitive-behavioral characteristics of a cohort of patients with amyotrophic lateral sclerosis (ALS) carrying TARDBP pathogenetic variants followed by an ALS referral center. METHODS: We enrolled all patients with ALS seen at the Turin ALS expert center in the 2009-2021 period who underwent extensive genetic testing and a neuropsychological battery encompassing executive function, verbal memory, language, visual memory, visuoconstructive abilities, attention/working memory, psychomotor speed, nonverbal intelligence, cognitive flexibility, social cognition, and behavior. Tests were compared with the Mann-Whitney U test on age-corrected, sex-corrected, and education-corrected scores. Cognition was classified as normal (ALS-CN); isolated cognitive impairment (ALSci), that is, evidence of executive and/or language dysfunction; isolated behavioral impairment (ALSbi), that is, identification of apathy; cognitive and behavioral impairment (ALScbi), that is, evidence meeting the criteria for both ALSci and ALSbi; and frontotemporal dementia (ALS-FTD). RESULTS: This study includes 33 patients with TARDBP pathogenetic variants (TARDBP-ALS) (median age 61 years [interquartile range (IQR) 53-67], 8 female [24.2%]) and 928 patients with ALS not carrying the pathogenic variant (WT-ALS) (median age 67 years [IQR 59-74], 386 female [41.6%]). TARDBP-ALS cases were also compared with 129 matched controls (median age 66 years [IQR 57.5-71.5], 55 female [42.6%]). TARDBP-ALS and WT-ALS patients were cognitively classified as ALS-CN (54% vs 58.8%, respectively), ALSci (21.2% vs 18.3%), ALSci (9.1% vs 9.5%), ALScbi (6.1% vs 6.0%), and ALS-FTD (9.1 vs 6.7%), with no significant difference (p = 0.623). Compared with controls, TARDBP-ALS had a worse performance in executive functions, visual memory, visuoconstructive abilities, verbal fluency, and the apathy behavioral component of FrSBe. The scores of performed tests, including all Edinburgh Cognitive and Behavioral ALS Screen subdomains, were similar in TARDBP-ALS and WT-ALS. DISCUSSION: TARDBP-ALS patients were significantly more impaired than controls in most examined domains but do not show any specific pattern of cognitive impairment compared with WT-ALS. Our findings are relevant both clinically, considering the effect of cognitive impairment on patients' decision-making and caregivers' burden, and in designing clinical trials for the treatment of patients carrying TARDBP pathogenetic variants.
引用
- Moglia C, Calvo A, Canosa A, et al. Cognitive and Behavioral Features of Patients With Amyotrophic Lateral Sclerosis Who Are Carriers of the TARDBP Pathogenic Variant. Neurology. 2024. PMID: 38261982. doi:10.1212/WNL.0000000000208082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。